Abstract
Diabetes mellitus is one of the leading diseases in the developed world. In order to better regulate blood glucose in a diabetic patient, improved modelling of insulin-glucose dynamics is a key factor in the treatment of diabetes mellitus. In the current work, the insulin-glucose dynamics in type II diabetes mellitus can be modelled by using a stochastic nonlinear state-space model. Estimating the parameters of such a model is difficult as only a few blood glucose and insulin measurements per day are available in a non-clinical setting. Therefore, developing a predictive model of the blood glucose of a person with type II diabetes mellitus is important when the glucose and insulin concentrations are only available at irregular intervals. To overcome these difficulties, we resort to online sequential Monte Carlo (SMC) estimation of states and parameters of the state-space model for type II diabetic patients under various levels of randomly missing clinical data. Our results show that this method is efficient in monitoring and estimating the dynamics of the peripheral glucose, insulin and incretins concentration when 10, 25 and 50 % of the simulated clinical data were randomly removed.
Similar content being viewed by others
Notes
A response model is a mathematical model describing the dynamics of the key internal states of a patient in response to a clinical test.
Abbreviations
- \(G\) :
-
Glucose concentration (mg/dl)
- \(M\) :
-
Multiplier of metabolic rates (dimensionless)
- \(Q\) :
-
Vascular blood flow rate (dl/min)
- \(r\) :
-
Metabolic production or consumption rate (mg/min)
- \(T\) :
-
Transcapillary diffusion time constant (min)
- \(t\) :
-
Time (min)
- \(V\) :
-
Volume (dl)
- \(I\) :
-
Insulin concentration (mU/l)
- \(M\) :
-
Multiplier of metabolic rates (dimensionless)
- \(m\) :
-
Labile insulin mass (U)
- \(P\) :
-
Potentiator (dimensionless)
- \(Q\) :
-
Vascular blood flow rate (dl/min)
- \(R\) :
-
Inhibitor (dimensionless)
- \(r\) :
-
Metabolic production or consumption rate (mU/min)
- \(S\) :
-
Insulin secretion rate (U/min)
- \(T\) :
-
Transcapillary diffusion time constant (min)
- \(t\) :
-
Time (min)
- \(V\) :
-
Volume (dl)
- \(X\) :
-
Glucose-enhanced excitation factor (dimensionless)
- \(Y\) :
-
Intermediate variable (dimensionless)
- \(\Gamma\) :
-
Normalized glucagon concentration (dimensionless)
- \(M\) :
-
Multiplier of metabolic rates (dimensionless)
- \(r\) :
-
Metabolic production or consumption rate (dl/min)
- \(t\) :
-
Time (min)
- \(V\) :
-
Volume (dl)
- \(\Psi\) :
-
Incretins concentration (pmol/l)
- \(r\) :
-
Metabolic production or consumption rate (pmol/min)
- \(t\) :
-
Time (min)
- \(V\) :
-
Volume (dl)
- \(\Gamma\) :
-
Glucagon
- \(M\) :
-
Incretins
- \(B\) :
-
Basal condition
- \(G\) :
-
Glucose
- \(I\) :
-
Insulin
- \(\infty\) :
-
Final steady state value
- \(BGU\) :
-
Brain glucose uptake
- \(GGU\) :
-
Gut glucose uptake
- \(HGP\) :
-
Hepatic glucose production
- \(HGU\) :
-
Hepatic glucose uptake
- \(I\Psi R\) :
-
Intestinal incretins release
- \(KGE\) :
-
Kidney glucose excretion
- \(KIC\) :
-
Kidney insulin clearance
- \(LIC\) :
-
Liver insulin clearance
- \(M\Gamma C\) :
-
Metabolic glucagon clearance
- \(P\Gamma C\) :
-
Plasma glucagon clearance
- \(P\Psi C\) :
-
Plasma incretins clearance
- \(P\Gamma R\) :
-
Pancreatic glucagon release
- \(PGU\) :
-
Peripheral glucose uptake
- \(PIC\) :
-
Peripheral insulin clearance
- \(PIR\) :
-
Pancreatic insulin release
- \(RBCU\) :
-
Red blood cell glucose uptake
- \(\infty\) :
-
Final steady state value
- \(A\) :
-
Hepatic artery
- \(B\) :
-
Brain
- \(G\) :
-
Gut
- \(L\) :
-
Liver
- \(P\) :
-
Periphery
- \(S\) :
-
Stomach
- \(C\) :
-
Capillary space
- \(F\) :
-
Interstitial fluid space
- \(l\) :
-
Liquid
- \(s\) :
-
Solid
References
Canadian Diabetes Association (2009) Diabetes facts
Groop LC, Widen E, Ferrannini E (1993) Insulin resistance and insulin deficiency in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods. Diabetologia 36:1326–1331
Basu A et al (2000) Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes 49:272–283
DeFronzo RA (1988) Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667–687
Vahidi O, Gopaluni RB, Kwok KE (2011) Detection of organ dysfunction in type II diabetic patients. American Control Conference (ACC) 3:4769–4774
Rajak A, Saxena K (2010) Achieving realistic and interactive clinical simulation using case based TheraSim’s therapy engine dynamically. In: Proceedings of the National Conference
Machan CM (2012) Type 2 diabetes mellitus and the prevalence of age-related cataract in a clinic population. Thesis, University of Waterloo, MSc
Wei WQ et al (2012) The absence of longitudinal data limits the accuracy of high-throughput clinical phenotyping for identifying type 2 diabetes mellitus subjects. Int J Med Inform 82:239–247
Briegel T, Tresp V (2002) A nonlinear state space model for the blood glucose metabolism of a diabetic (Ein nichtlineares Zustandsraummodell fur den Blutglukosemetabolismus eines Diabetik-ers). at-Automatisierungstechnik 50.5
Tresp V, Briegel T (1998) A solution for missing data in recurrent neural networks with an application to blood glucose prediction. Adv Neural Inf Process Syst 10:971–977
Tresp V, Briegel T, Moody J (1999) Neural-network models for the blood glucose metabolism of a diabetic. In: Neural Networks, IEEE 10.5
El-Jabali AK (2005) Neural network modeling and control of type 1 diabetes mellitus. Bioprocess Biosyst Eng 27:75–79
Mougiakakou SG (2006) Neural network based glucose-insulin metabolism models for children with type 1 diabetes. Medicine
Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Investig 68(6):1456
Sorensen JT (1985) A Physiological Model of Glucose Metabolism in Man and its Use to De- sign and Assess Improved Insulin Therapies for Diabetes. PhD thesis. Ph.D. Thesis, Massachusetts Institute of Technology
Vahidi O et al (2011) Developing a physiological model for type II diabetes mellitus. Biochem Eng J 55:7–16
Vahidi O (2013) Dynamic modeling of glucose metabolism for the assessment of type II diabetes mellitus. PhD Thesis. The University of British Columbia
Khatibisepehr S, Huang B (2008) Dealing with irregular data in soft sensors: Bayesian method and comparative study. Ind Eng Chem Res 47(22):8713–8723
Dempster AP, Laird NM, Rubin DB (1977) Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc Ser B (Methodological) 39(1):1–38
Gopaluni RB (2008) A particle fillter approach to identification of nonlinear processes under missing observations. Can J Chem Eng 86(6):1081–1092
Deng J, Huang B (2011) Bayesian method for identification of constrained nonlinear processes with missing output data. Am Control Conf 3:96–101
Pillonetto G et al (2002) Minimal model S(I)=0 problem in NIDDM subjects: nonzero Bayesian estimates with credible confidence intervals. Am J Physiol Endocrinol Metab 282(3):E564–E573
Cobelli C, Caumo A, Omenetto M (1999) Minimal model SG overestimation and SI underestimation: improved accuracy by a Bayesian two-compartment model. Am J Physiol 277(3):E481–E488
Sparacino G (2000) Maximum-likelihood versus maximum a posteriori parameter estimation of physiolog- ical system models: the C-peptide impulse response case study. IEEE Trans 47(6):801–811
Tulsyan A et al (2013) On simultaneous on-line state and parameter estimation in non-linear state- space models. J Process Control 23(4):516–526
Ekram F (2012) A feedback glucose control strategy for type II diabetes mellitus based on fuzzy logic. Can J Chem Eng 90:1411–1417
Vahidi O, Kwok KE (2010) Development of a physiological model forpatients with type 2 diabetes mellitus. Control Conference (ACC)
Man CD, Camilleri M, Cobelli C (2006) A system model of oral glucose absorption: validation on gold standard data. IEEE Trans Biomed Eng 53(12):2472–2478
Filip KK et al (2007) Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes 56(8):1951–1959
Knop FK et al (2007) Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus. Diabetologia 50(4):797–805
Gardner IA (2002) The utility of Bayes theorem and Bayesian inference in veterinary clinical practice and research. Aust Vet J 80(12):758–761
Acknowledgments
We would like to thank Dr. Omid Vahidi for suggestions and technical support.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
Glucose sub-model
The mass balance equation over each compartment in the glucose sub-model results in following equations:
A detailed description about the metabolic rates is available in [15]. The general form of the metabolic production and consumption rates in each organ is as follows:
and multipliers have the following general form:
The glucose absorption model that calculates the glucose appearance rate into the blood stream following an oral glucose intake is considered in the gut compartment of the glucose sub-model as follows:
Incretins sub-model
The incretins production is calculated from the following differential equation:
The mass balance equation over the incretins compartment results in:
Insulin sub-model
The mass balance equation over the compartments in the insulin sub-model results in following equations:
The pancreas model contains two compartments. The pancreas model equations include mass balance equations over compartments and correlations between variables. The mass balance equation over each compartment results in:
The steady state mass balance equation around the storage compartment is:
where \(m_0\) is the labile insulin quantity at a glucose concentration of zero. The rest of the equations for the pancreas model are:
Glucagon sub-model
The glucagon sub-model has one mass balance equation over the whole body as follows:
Rights and permissions
About this article
Cite this article
Barazandegan, M., Ekram, F., Kwok, E. et al. Assessment of type II diabetes mellitus using irregularly sampled measurements with missing data. Bioprocess Biosyst Eng 38, 615–629 (2015). https://doi.org/10.1007/s00449-014-1301-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00449-014-1301-7